Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • EpiPen

CTech 24/7

  • Are AI tools making us smarter or just lazier?
  • Nothing Phone 3 review: Stylish, capable, but not quite a flagship
  • Nothing Phone 3 review: Stylish, capable, but not quite a flagship
  • From red tape to revenue: The growth of business-to-government partnerships
More stories in CTech

EpiPen

4 stories about EpiPen
  • Teva's Israeli headquarters. Photo: EPA

    Teva Jumps on NYSE on a Bit of Good News

    21.08.19|Hezi SternlichtAn opioid-abuse lawsuit settlement reached by drugmakers Endo and Allergan Tuesday could bode well for Teva’s legal future, as does the release of an FDA-approved generic version of EpiPen JR

  • EpiPen. Photo: AFP

    Teva, Mylan Drop on Announcement of Epinephrine Injector Rival

    09.12.18|Lilach BaumerNovartis’ U.S. division Sandoz announced a planned release for early 2019. The company will sell its drug, which lacks the EpiPen’s auto-injector, for $250 a pair out of pocket, compared to Mylan and Teva’s $300

  • Mylan's EpiPen. Photo: AFP

    Teva’s Generic EpiPen Now Available in the U.S. in Limited Numbers

    28.11.18|Lilach BaumerIn August, the Israel-headquartered drugmaker won approval to market the first generic EpiPen auto-injectors in the U.S.

  • Students. Photo: Shutterstock

    Teva’s EpiPen Won’t Hit U.S. Market in Time for School Year, Report Says

    26.08.18|Dror ReichThe Israeli drugmaker received approval for a first generic version of Mylan’s auto-injector earlier this month

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive